The global soft-tissue robotic-assisted surgery (RAS) market is undergoing structural realignment, characterised by accelerating clinical adoption, broadening procedural indications, and an intensifying multi-platform challenge to incumbent monopolies. On September 1st, 2026, Medtronic plc announced an approximately $700 million strategic investment in Cornerstone Robotics, a Hong Kong-headquartered surgical robotics innovator. Concurrently, Medtronic secured exclusive commer

The governance reforms enacted in late 2025 have established a highly disciplined, efficient capital allocation framework at Medtronic. Under the oversight of the Growth and Operating Committees, corporate leadership has successfully transitioned from a period of operational consolidation to an offensive M&A posture. The acquisitions of CathWorks, Scientia Vascular, and SPR Therapeutics demonstrate this strategic alignment, targeting high-growth, minimally invasive, and softw